In collaboration with Australasian Society of Diagnostic Genomics (ASDG), this module qualitatively assesses laboratory performance in the detection of TP53 deletions at 17p13.1 in chronic lymphocytic leukaemia (CLL) using fluorescence in-situ hybridisation (FISH).
Frequency (No of surveys/year)1
Cases/samples per survey3
Sample TypeInterphase nuclei (bone marrow)
Sample volumeTwo slides provided in each case
Measurand/TestMolecular/cytogenetic testing for TP53 deletion in 17p13.1.
Storage and HandlingStore samples at room temperature or according to your standard operating procedure, upon receipt.
Available to order in myQAP under the Haematology Discipline
Product details last updated on August 18, 2021